{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:19:49Z","timestamp":1769433589205,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007445","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000}}],"reference-count":53,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007445.pub2","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T14:33:44Z","timestamp":1271169224000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Chlorpromazine for psychosis induced aggression or agitation"],"prefix":"10.1002","volume":"2010","author":[{"given":"Uzair","family":"Ahmed","sequence":"first","affiliation":[{"name":"North Yorkshire and York PCT; System House, Clifton Moor Amy Johnson way York UK YO30 4XT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Jones","sequence":"additional","affiliation":[{"name":"University of Bristol; Academic Unit of Psychiatry, Community Based Medicine; Cotham House, Cotham Hill Bristol UK BS6 6JL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive E","family":"Adams","sequence":"additional","affiliation":[{"name":"University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health, Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007445.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0033-3182(73)71377-3","article-title":"Rapid tranqulization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine","volume":"14","author":"Man","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/ajp.116.11.973","article-title":"Evaluation of tranquilizing drugs in the management of acute mental disturbance","volume":"117","author":"Abse","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007445.pub2-BIB0003|cit3","first-page":"599","article-title":"The comparison study on curing agitation by haloperidol and chlorpromazine venoclysis","volume":"16","author":"Chen","year":"2004","journal-title":"Medical Journal of Chinese People Health"},{"issue":"8","key":"10.1002\/14651858.CD007445.pub2-BIB0004|cit4","first-page":"434","article-title":"Pinoxepin vs chlorpromazine: A double-blind comparison","volume":"9","author":"Claghorn","year":"1967","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD007445.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD007445.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-198809000-00009","article-title":"High potency neuroleptics and violence in schizophrenics","volume":"176","author":"Herrera","year":"1988","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007445.pub2-BIB0007|cit7","first-page":"151","article-title":"A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: A double blind controlled study on the treatment of chronic hospitalized, schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experimental Psychology"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1192\/bjp.106.445.1417","article-title":"Phenothiazine side effects. Comparison of two major tranquillizers","volume":"106","author":"Somerville","year":"1960","journal-title":"Journal of Mental Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007445.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF01573366","article-title":"A double blind comparison of thioridazine and chlorpromazine","volume":"34","author":"Stabenau","year":"1964","journal-title":"Psychiatric Quarterly"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/ajp.121.6.597","article-title":"Are tranquilizer combinations more effective than a single tranquilizer?","volume":"121","author":"Talbot","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"34","key":"10.1002\/14651858.CD007445.pub2-BIB0011|cit11","first-page":"945","article-title":"Chlorpromazine, clotiapine and thioridazine - A comparative clinical trial on bantu psychotic patients","volume":"45","author":"Wyk","year":"1971","journal-title":"South African Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD007445.pub2-BIB0012|cit12","first-page":"784","article-title":"A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses","volume":"11","author":"Wadzisz","year":"1969","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0015|cit15","volume-title":"Psychotropic drug directory","author":"Bazier","year":"2007"},{"issue":"2","key":"10.1002\/14651858.CD007445.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003729.pub2","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0018|cit18","volume-title":"British National Formulary","author":"British National Formulary","year":"March 2008"},{"issue":"4","key":"10.1002\/14651858.CD007445.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001943.pub2","article-title":"Loxapine for schizophrenia","author":"Chakrabarti","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0020|cit20","unstructured":"Central Intelligence Agency The World Factbook https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/pb.18.3.138","article-title":"Drug management of disturbed behaviour by psychiatrists","volume":"18","author":"Cunnane","year":"1994","journal-title":"Psychiatric Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD007445.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007445.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007445.pub2-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Gibson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for systematic reviews of interventions 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org 2005","DOI":"10.1002\/9780470712184"},{"issue":"7625","key":"10.1002\/14651858.CD007445.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bmj.39339.448819.AE","article-title":"Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine","volume":"335","author":"Huf","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007445.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","author":"Huf","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0032|cit32","volume-title":"Clinical Handbook of Psychotropic Drugs","author":"Kalyana","year":"2006"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0033|cit33","volume-title":"Psychotropic Drugs","author":"Keltner","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD007445.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004278.pub2","article-title":"Haloperidol versus chlorpromazine for schizophrenia","author":"Leucht","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007445.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"Lopez-Munez","year":"2005","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"9263","key":"10.1002\/14651858.CD007445.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007445.pub2-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002084.pub2","article-title":"Containment strategies for people with serious mental illness","author":"Muralidharan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0039|cit39","unstructured":"NHS Business Services Authority Prescription Pricing Division http:\/\/www.ppa.org.uk\/ppa\/ppa_main.htm"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0040|cit40","unstructured":"National Collaborating Centre for Nursing and Supportive Care The short-term management of disturbed\/violent behaviour in in-patient psychiatric settings and emergency departments http:\/\/www.nice.org.uk\/Guidance\/CG25\/NiceGuidance\/pdf\/English (accessed August 2008)"},{"issue":"7625","key":"10.1002\/14651858.CD007445.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.39341.608519.BE","article-title":"Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine","volume":"335","author":"Raveendran","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007445.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001163","article-title":"Seclusion and restraint for people with serious mental illnesses","author":"Sailas","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007445.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1017\/S0033291700045244","article-title":"WHO international pilot study of schizophrenia","volume":"2","author":"Sartorius","year":"1972","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007445.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seaman","year":"2004","journal-title":"Synapse"},{"issue":"2","key":"10.1002\/14651858.CD007445.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0447.2000.9r004.x","article-title":"Mental health economic studies from developing countries reviewed in the context of those from developed countries","volume":"101","author":"Shah","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0046|cit46","first-page":"761","article-title":"Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys","volume":"41","author":"Swanson","year":"1990","journal-title":"Hospital and Community Psychiatry"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1176\/ajp.139.2.212","article-title":"Assaultive behavior among chronic inpatients","volume":"139","author":"Tardiff","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"7417","key":"10.1002\/14651858.CD007445.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.327.7417.708","article-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine","volume":"327","author":"TREC Collaborative Group","year":"2003","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007445.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1136\/bmj.39034.609074.94","article-title":"Chlorpromazine: unlocking psychosis","volume":"334","author":"Turner","year":"2007","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD007445.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"1","key":"10.1002\/14651858.CD007445.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006391","article-title":"Benzodiazepines for schizophrenia","author":"Volz","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0052|cit52","volume-title":"WHO Essential Medicines List","author":"World Health Organisation","year":"2007"},{"key":"10.1002\/14651858.CD007445.pub2-BIB0053|cit53","unstructured":"World Psychiatric Association The usefulness and use of second-generation antipsychotic medications\u00a0(An update of the review of evidence and recommendations by a task force of the World Psychiatric Association) http:\/\/www.peoplewho.org\/documents\/WPA2ndgenanti-pDOC.doc Yokohama, Japan"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007445.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:25:35Z","timestamp":1761218735000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007445.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007445.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}